tm
Seeing Is Believing
tm
Seeing Is Believing
TVTX is currently covered by 11 analysts with an average price target of $55.5. This is a potential upside of $10.85 (-17.18%) from yesterday's end of day stock price of $67.01.
Travere Therapeutics's activity chart (see below) currently has 178 price targets and 169 ratings on display. The stock rating distribution of TVTX is 86.84% BUY and 13.16% HOLD.
Analysts average stock forecasts to be materialized ratio is 87.07% with an average time for these price targets to be met of 434.94 days.
Highest price target for TVTX is $78, Lowest price target is $31, average price target is $55.5.
Most recent stock forecast was given by LIISA BAYKO from EVERCORE on 10-Aug-2026.
Currently out of the existing stock ratings of TVTX, 33 are a BUY (86.84%), 5 are a HOLD (13.16%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Nov-2020
$78
$12.29 (18.70%)
$68
Buy Since 17-Apr-2023
$75
$9.29 (14.14%)
$61
Buy Since 22-May-2023
$75
$9.29 (14.14%)
$60
Buy Since 27-Sep-2024
$75
$9.29 (14.14%)
$65
Buy Since 17-May-2021
$62
$-3.71 (-5.65%)
$56
What is TVTX (Travere Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TVTX (Travere Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TVTX (Travere Therapeutics)?
Which analyst is the currently most bullish on TVTX (Travere Therapeutics)?
Which analyst is the currently most reserved on TVTX (Travere Therapeutics)?
